Jo Anne Zujewski, MD Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment National Cancer Institute May, 2011 Targeted Therapy.
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology, University of Washington School of Medicine.
Proteomics Informatics – Molecular signatures (Week 11)
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance
Pharmacogenomics, personalized medicine and the drug development process. Michael G. Walker, Ph.D. [email protected].
Lessons From Clinical Trials of Targeted Therapies for Cancer George W. Sledge M.D. Indiana University Simon Cancer Center.
v01p0054
Pharmacogenomics, personalized medicine and the drug development process.
Tamoxifen, Raloxifene , and Exemestane in the Chemoprevention of Breast Cancer
